Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,399,571
+$2,710,030 QoQ
Shares Held
14,911
+95.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#796
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abundance Wealth Counselors holds $44,555,696 across 12 Drug Manufacturers - General names. AMGN ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
30,368 | $7,641,803 | |
| 2 | JNJ |
Johnson & Johnson
|
23,066 | $5,858,072 | |
| 3 | AMGN |
Amgen Inc
This page
|
14,911 | $5,399,571 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
91,814 | $5,290,322 | |
| 5 | NVS |
Novartis AG
|
32,213 | $5,048,421 | |
| 6 | LLY |
ELI LILLY & Co
|
4,027 | $4,830,105 | |
| 7 | GSK |
GSK plc
|
65,979 | $3,458,619 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,139 | $2,797,041 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,399,571 | 14,911 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,689,541 | 7,644 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,434,531 | 7,438 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,139,640 | 7,582 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,245,127 | 8,041 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,574,026 | 8,262 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,085,641 | 8,002 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,592,179 | 8,045 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,640,514 | 8,451 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,614,038 | 9,194 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,582,099 | 8,965 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,394,382 | 8,909 | Shares | Sole | 2023-10-30 | |
| 2023-03-31 | $2,182,519 | 9,028 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,336,182 | 8,895 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,976,307 | 8,768 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,083,621 | 8,564 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,028,869 | 8,390 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,995,483 | 8,870 | Shares | Sole | 2022-01-18 | |
| 2021-06-30 | $1,996,312 | 8,190 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,438,121 | 5,780 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,221,335 | 5,312 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,215,901 | 4,784 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,084,956 | 4,600 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $441,140 | 2,176 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||